Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP

Consolidated financial statements For the six-month period Unit: Million Baht Ended 30 June 2017 (6M) % 2016 (6M) % YoY Dif. +/- YoY % +/- Financing cost 1.26 0.2% 3.01 0.7% - 1.75 -58.16% Income tax expenses

customer orders and other chemicals decreased lower than the sale target. However, the company has focused on increasing the margin in sales which can be done above the average target of 18%. Manufacturing

addition, the economic impact of Covid-19 will be only fully visible in the Q2-Q4 period of the year. However, as our business is essential to many manufacturing processes, and as we are quite diversified

Cost on Setting up Manufacturing Plant, Warehouse and Office Building 209.46 14.38 3. Machine and Equipment 960.51 65.95 4. Transportation (Truck, Crane, Combilift, Forklift) 43.70 3.00 5. Financing Cost

1 No. ECF2 029/2561 28 June 2018 Subject The Entering into an Investment of the construction of the Manufacturing Plant and Distributing of the Medium Density Fiber Board or MDF Board in Narathiwat

commercial and passenger cars. Export-related manufacturing production, especially automotive, has continued to improve. The consensus view for 4% GDP growth in 2018 maybe revised upwards given the strong end

Baht 76 and gross profit margin for the second quarter of 2019 was decreased from 20% to 14%. It was due to the increase in cost of sales, which was the result of manufacturing expenses, which were

details: Revenues Structure 1. The revenues of manufacturing and distributing of Food Ingredients that are classified into 6 categories as the followings: 1.1 Flavour, Fragrance & Color 1.2 Food Coating 1.3

is likely leaving its mark on the Thai economy. Private consumption growth moderated noticeably in Q1 while private investment fell, reflecting dampening domestic demand. Manufacturing output